135 related articles for article (PubMed ID: 18261924)
1. A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population.
Blanchette CM; Simoni-Wastila L; Zuckerman IH; Stuart B
Ann Epidemiol; 2008 Apr; 18(4):316-21. PubMed ID: 18261924
[TBL] [Abstract][Full Text] [Related]
2. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
Schlienger RG; Fischer LM; Jick H; Meier CR
Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
[TBL] [Abstract][Full Text] [Related]
3. Special Report from the CDC Antidepressant subclass use and fall risk in community-dwelling older Americans.
Haddad YK; Luo F; Bergen G; Legha JK; Atherly A
J Safety Res; 2021 Feb; 76():332-340. PubMed ID: 33653566
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults.
Haddad YK; Kakara R; Marcum ZA
J Am Geriatr Soc; 2022 May; 70(5):1450-1460. PubMed ID: 35132611
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
[TBL] [Abstract][Full Text] [Related]
6. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.
Sauer WH; Berlin JA; Kimmel SE
Circulation; 2003 Jul; 108(1):32-6. PubMed ID: 12821544
[TBL] [Abstract][Full Text] [Related]
7. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.
Cohen HW; Gibson G; Alderman MH
Am J Med; 2000 Jan; 108(1):2-8. PubMed ID: 11059434
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
[TBL] [Abstract][Full Text] [Related]
9. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis.
Becker C; Jick SS; Meier CR
Ophthalmology; 2017 Nov; 124(11):1635-1639. PubMed ID: 28571893
[TBL] [Abstract][Full Text] [Related]
10. Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma.
Chen HY; Lin CL; Lai SW; Kao CH
J Clin Psychiatry; 2016 Jun; 77(6):e692-6. PubMed ID: 27135704
[TBL] [Abstract][Full Text] [Related]
11. Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use.
Blanchette CM; Simoni-Wastila L; Shaya F; Orwig D; Noel J; Stuart B
Am J Health Syst Pharm; 2009 Feb; 66(4):366-72. PubMed ID: 19202046
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study.
Marcum ZA; Perera S; Thorpe JM; Switzer GE; Castle NG; Strotmeyer ES; Simonsick EM; Ayonayon HN; Phillips CL; Rubin S; Zucker-Levin AR; Bauer DC; Shorr RI; Kang Y; Gray SL; Hanlon JT;
Ann Pharmacother; 2016 Jul; 50(7):525-33. PubMed ID: 27066988
[TBL] [Abstract][Full Text] [Related]
14. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.
Tata LJ; West J; Smith C; Farrington P; Card T; Smeeth L; Hubbard R
Heart; 2005 Apr; 91(4):465-71. PubMed ID: 15772201
[TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
Meier CR; Schlienger RG; Jick H
Br J Clin Pharmacol; 2001 Aug; 52(2):179-84. PubMed ID: 11488775
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors and myocardial infarction.
Sauer WH; Berlin JA; Kimmel SE
Circulation; 2001 Oct; 104(16):1894-8. PubMed ID: 11602490
[TBL] [Abstract][Full Text] [Related]
17. Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis.
Sanchez-Ruiz JA; Leibman NI; Larson NB; Jenkins GD; Ahmed AT; Nunez NA; Biernacka JM; Winham SJ; Weinshilboum RM; Wang L; Frye MA; Ozerdem A
J Womens Health (Larchmt); 2023 Nov; 32(11):1229-1240. PubMed ID: 37856151
[No Abstract] [Full Text] [Related]
18. Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case-control study.
Alqdwah-Fattouh R; Rodríguez-Martín S; de Abajo FJ; González-Bermejo D; Gil M; García-Lledó A; Bolúmar F
Br J Clin Pharmacol; 2020 Oct; 86(10):2040-2050. PubMed ID: 32250461
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
[TBL] [Abstract][Full Text] [Related]
20. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
